Galmed Pharmaceuticals Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (18)

Latest Posts

About This Stock More About This Stock
5 Extremely Lucrative Biotechs To Track Now
Article By: TipRanks
Wednesday, September 12, 2018 3:22 PM EDT
September is typically an ugly month for stocks. Biotech stocks march to a different tune. They can spike massively on positive news — be it key trial results or regulatory approvals.
In this article: SRNE, GLMD, TOCA, SBPH, OBSV
Read
5 Biotech Stocks To Watch As Interest In NASH Increases
Article By: Arpita Dutt
Thursday, September 22, 2016 1:45 PM EDT
The market is suddenly abuzz about nonalcoholic steatohepatitis or NASH, a common but often “silent” liver disease. Several companies are working on developing treatments for NASH – the market could be worth billions of dollars.
In this article: ICPT, CNAT, GALT, ENTA, GLMD Also: AGN
Read
Week In Review: Sorrento Therapeutics Raises $150 Million From China Investors
Article By: ChinaBio® Today
Saturday, June 11, 2016 7:21 PM EDT
Sorrento Therapeutics (NSDQ: SRNE), a San Diego-China biopharma, closed a $150 million private placement led by Ally Bridge Group, which is headquartered in Hong Kong.
In this article: SRNE, BABA, GLMD, KANG
Read
Premarket Biotech Digest 2016-03-31: VRX Debt, OPK RAYALDEE NDA, ICPT Presentation
Article By: KKD Healthcare Analytics
Thursday, March 31, 2016 9:10 AM EDT
Daily premarket biotech digest for March 31, 2016.
In this article: AGN, JNJ, OPK, PFE, VRX, ACAD, ANAC, ICPT, SRPT, GLMD, CTRV, BVXV, TKPYY
Read
Biotechs With Upside Possibilities Target Ebola And Liver Disease: MLV & Co.'s Vernon Bernardino
Article By: The Life Sciences Report
Wednesday, September 10, 2014 3:43 PM EDT
In this interview with The Life Sciences Report, Vernon Bernardino of MLV & Co. brings some clarity and perspective to investors who could reap windfalls from small-cap names in which shareholder value has yet to be created and realized.
In this article: NBS, GALT, BCRX, SHPG, DVAX, ICPT, ABBV, CNAT, GLMD, IMNP
Read

PARTNER HEADLINES

Latest Tweets for $GLMD

No tweets yet!